Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey

Background: Soon after the COVID-19 pandemic was declared, a pharmaceutical company expressed rapid interest in developing a safe and effective vaccine candidate to contain the spread of SARS-CoV-2 infections. The FDA approved the Pfizer-BioNTech, AstraZeneca, Moderna, and Janssen vaccines. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqurashi, Afnan, Sindy, Enas A., Dosh, Heba, Khayat, Sumaya Z., Alqarna, Lujain M., Sodagar, Wafa M., Samannodi, Mohammed, Alwafi, Hassan, Salawati, Emad, Almatrafi, Mohammed A., Ekram, Rakan, Bagadood, Rehab M., Alsafi, Radi, Assaggaf, Hamza M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657038/
https://www.ncbi.nlm.nih.gov/pubmed/36360769
http://dx.doi.org/10.3390/ijerph192113889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657038/
https://www.ncbi.nlm.nih.gov/pubmed/36360769
http://dx.doi.org/10.3390/ijerph192113889

Ejemplares similares